Loading…
BioLife Solutions, Inc. is projected to rise to $35.00 by 2027, a +24% move from its current price of $28.18. BLFS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $27.53 | $28.19 | $28.86 | +0.03% |
| Jul 15 | $27.27 | $28.20 | $29.16 | +0.06% |
| Jul 16 | $27.08 | $28.21 | $29.38 | +0.09% |
| Jul 17 | $26.91 | $28.22 | $29.58 | +0.13% |
| Jul 18 | $26.77 | $28.22 | $29.76 | +0.16% |
| Jul 19 | $26.65 | $28.23 | $29.91 | +0.19% |
| Jul 20 | $26.53 | $28.24 | $30.06 | +0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $26.53 | $28.24 | $30.06 | +0.22% |
| Week 2 | $25.91 | $28.30 | $30.92 | +0.44% |
| Week 3 | $25.46 | $28.37 | $31.61 | +0.66% |
| Week 4 | $25.09 | $28.43 | $32.21 | +0.88% |
| Week 5 | $24.77 | $28.49 | $32.76 | +1.10% |
| Week 6 | $24.50 | $28.55 | $33.28 | +1.32% |
| Week 7 | $24.25 | $28.62 | $33.76 | +1.55% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. Its catalog includes proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines.
The ThawSTAR line includes automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags, and the evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. The company markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
BioLife Solutions, Inc. (BLFS) is a healthcare company focused on bioproduction for CGT. It trades at $27.50 with a market cap of $1.34B and is ranked 2328. The current price and market position place it among mid-cap healthcare names with a defined niche in biopreservation and bioprocessing equipment.
A major floor 35.6% below — a decisive break under it would weaken the trend.
The nearest floor, 12.0% below — buyers have tended to step in here.
Price is pressing into resistance (1.7% away) — a breakout level to watch.
A major ceiling 10.3% above — clearing it would confirm fresh momentum.
Key BLFS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BLFS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $27.86 | Buy | $27.97 | Buy |
| MA 10 | $28.11 | Buy | $27.76 | Buy |
| MA 20 | $27.06 | Buy | $27.19 | Buy |
| MA 50 | $25.02 | Buy | $25.52 | Buy |
| MA 100 | $22.79 | Buy | $24.32 | Buy |
| MA 200 | $24.08 | Buy | $23.90 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.66 | Neutral |
| Stoch RSI (14) | 63.66 | Neutral |
| CCI (20) | 68.09 | Neutral |
| Williams %R (14) | -12.63 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | 13.67 | Buy |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 87.37 | Sell |
| TRIX (15) | 0.50 | Buy |
| Awesome (5,34) | 1.27 | Buy |
| Ultimate (7,14,28) | 54.35 | Neutral |
| Momentum (10) | 0.68 | Buy |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 27.76 | Buy |
| ADX (14) | 20.68 | Buy |
| ATR (14) | 0.57 | Info |
The 30-day technical picture is bullish, with momentum and trend supported by key moving averages and a defined trading range. RSI14 sits at 60, while the stock trades above its short- and longer-term averages.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $18.15 | $28.18 | $38.36 | 0% | Neutral | |
| $28.22 | $35.00 | $45.71 | +24% | Bullish | |
| $32.20 | $40.91 | $55.20 | +45% | Bullish | |
| $41.33 | $53.54 | $74.12 | +90% | Bullish | |
| $48.29 | $63.65 | $90.04 | +126% | Bullish | |
| $55.03 | $73.69 | $106.23 | +161% | Bullish | |
| $59.48 | $80.82 | $118.50 | +187% | Bullish | |
| $60.37 | $83.15 | $123.81 | +195% | Bullish | |
| $69.71 | $97.27 | $146.92 | +245% | Bullish | |
| $76.03 | $107.40 | $164.38 | +281% | Bullish | |
| $121.75 | $181.82 | $294.18 | +545% | Bullish | |
| $240.31 | $394.31 | $692.24 | +13.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $18.15 | $28.18 | $34.17 | +0.00% |
| August 2026 | $24.90 | $29.27 | $35.26 | +3.88% |
| September 2026 | $24.51 | $29.00 | $35.27 | -0.95% |
| October 2026 | $24.86 | $29.56 | $36.25 | +1.95% |
| November 2026 | $25.75 | $30.75 | $37.97 | +4.02% |
| December 2026 | $25.74 | $30.87 | $38.36 | +0.40% |
Click any year to see its month-by-month BLFS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
BioLife Solutions, Inc.'s 2026 outlook centres on $28.18, within a $18.15 to $38.36 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, BLFS could reach as high as $45.71, with a base case around $35.00 and support toward $28.22 — roughly +24% from $28.18. Buyers look set to stay in control over this stretch.
Expect BLFS to range from $32.20 to $55.20 through 2028. The $40.91 average target implies a +45% move from current prices. That is up +17% on the projected 2027 average. Momentum favours further upside here.
The BLFS price prediction for 2029 points to an average of $53.54 (low $41.33, high $74.12) — a potential gain of +90% on today's $28.18. Buyers look set to stay in control over this stretch.
In 2030, BLFS is projected to trade between $48.29 and $90.04, averaging $63.65 — a potential gain of +126% from today's $28.18. That is up +19% on the projected 2029 average. Momentum favours further upside here.
BioLife Solutions, Inc.'s 2031 outlook centres on $73.69, within a $55.03 to $106.23 range. That is up +16% on the projected 2030 average. That marks a +161% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, BLFS could reach as high as $118.50, with a base case around $80.82 and support toward $59.48 — roughly +187% from $28.18. Momentum favours further upside here.
Expect BLFS to range from $60.37 to $123.81 through 2033. The $83.15 average target implies a +195% move from current prices. That is up +3% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The BLFS price prediction for 2034 points to an average of $97.27 (low $69.71, high $146.92) — a potential gain of +245% on today's $28.18. Momentum favours further upside here.
In 2035, BLFS is projected to trade between $76.03 and $164.38, averaging $107.40 — a potential gain of +281% from today's $28.18. That is up +10% on the projected 2034 average. Buyers look set to stay in control over this stretch.
BioLife Solutions, Inc.'s 2040 outlook centres on $181.82, within a $121.75 to $294.18 range. That is up +69% on the projected 2035 average. That marks a +545% change versus current levels. Momentum favours further upside here.
By 2050, BLFS could reach as high as $692.24, with a base case around $394.31 and support toward $240.31 — roughly +13.0x from $28.18. Buyers look set to stay in control over this stretch.
Investing $1,000 in BLFS today (≈ 35.48616 BLFS) could be worth
$13,992.6
+$12,992.6 (+1299%) by 2050 · US Dollar
Based on the average projected BLFS price of $394.31 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BLFSwould be worth at today's price.
$1,000 invested in BLFS on Jul 10, 2025 (≈ 44.014086 BLFS) would be worth
$1,240.32
+$240.32 (+24.0%) today · 1.24× · US Dollar
Based on a BLFS entry price of $22.72 vs. today's $28.18.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $28.11 | $1,002.49 | +0.2% |
| 1 month ago | $26.66 | $1,057.01 | +5.7% |
| 3 months ago | $19.74 | $1,427.56 | +42.8% |
| 6 months ago | $24.04 | $1,172.21 | +17.2% |
| 1 year ago | $22.72 | $1,240.32 | +24.0% |
| All time (5.0y) ago | $44.71 | $630.28 | -37.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BLFS forecast.
Our base-case forecast reaches $56.00 around 2030.
Implied market cap at $56.00: $2.74B
The multi-year forecast shows a strong upward trajectory. In 2030 the average price is $63.07 with an ROI of 129.3%. By 2040 the average rises to $170.41 with an ROI of 519.7%, and by 2050 the average is $363.05 with an ROI of 1220.2%.
The 2027 forecast projects an average of $34.14 (ROI 24.1%), followed by continued expansion through 2029 (avg $51.58, ROI 87.5%). The 2026 forecast shows an average of $27.50 (ROI 0%), with a 30-day range from $18.15 to $37.48. These figures illustrate a bullish long-term outlook, though they are estimates and subject to uncertainty and variation in actual results.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $63.07, with a low of $46.53 and a high of $92.22, and an ROI of 129.3%. (Sentiment: BULLISH)
Forecasts indicate bullish momentum from 2027 onward, with 2027 avg $34.14 (ROI 24.1%), 2028 avg $39.21 (ROI 42.6%), 2029 avg $51.58 (ROI 87.5%), 2030 avg $63.07 (ROI 129.3%), 2040 avg $170.41 (ROI 519.7%), and 2050 avg $363.05 (ROI 1220.2%). The 2026 line shows avg $27.50 (ROI 0%). These are estimates and not guarantees.
Yes. The 2035 forecast shows an average of $99.29 with a max of $158.74, and the 2040 forecast shows an average of $170.41, which would exceed $100.
Current price is $27.50 and market cap is $1.34B. The asset is ranked 2328.
The 30-day range is $22.88 to $33.05. RSI14 is 60, and annualized volatility is 50%.
BioLife Solutions, Inc. Community Discussion
0Share your BioLife Solutions, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.